{
  "docId": "019de074-7bfd-70c0-985e-370853614892",
  "docSlug": "be9cd2ecd1a9b4702566620e9f2aa170",
  "documentTitle": "Bionomics | Results Presentation Deck | 27 slides",
  "authorId": "bionomics",
  "authorName": "Bionomics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-03-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 26,
  "pageCount": 27,
  "prevPage": 25,
  "nextPage": 27,
  "slideType": "closing_ask",
  "function": "state_next_steps",
  "density": "overcrowded",
  "nDataPoints": 0,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-7bfd-70c0-985e-370853614892/26",
  "deckHref": "/decks/019de074-7bfd-70c0-985e-370853614892",
  "deckJsonHref": "/decks/019de074-7bfd-70c0-985e-370853614892.json",
  "deckAnchorHref": "/decks/019de074-7bfd-70c0-985e-370853614892#slide-26",
  "components": [
    {
      "bbox": {
        "h": 0.075,
        "w": 0.929,
        "x": 0.035,
        "y": 0.537
      },
      "kind": "list",
      "text": "Initiate Bionomics' transformation into a late-clinical stage company with enhanced US focus",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "530fc0d7-c50c-4fd8-b99b-f2908e8ecc78",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.075,
        "w": 0.929,
        "x": 0.035,
        "y": 0.21
      },
      "kind": "list",
      "text": "Request and conduct FDA End-of-Phase 2 Meeting by Q3 2023 to discuss the registrational program design",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "854959e3-9a78-4d71-9ade-035b208c1cf2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.075,
        "w": 0.929,
        "x": 0.035,
        "y": 0.319
      },
      "kind": "list",
      "text": "Initiate start-up activities for Ph3 study execution targeting First Patient In in late 2023-early 2024",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "aa19b43c-12a3-420c-9bc7-d29a53679109",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.075,
        "w": 0.929,
        "x": 0.035,
        "y": 0.646
      },
      "kind": "list",
      "text": "Continue execution of PTSD program targeting a read-out in mid 2023",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b0b264fe-108b-4f7e-b34c-dfc6f51d37c1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.075,
        "w": 0.929,
        "x": 0.035,
        "y": 0.428
      },
      "kind": "list",
      "text": "Kick-off financing and partnering discussions",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c2a8f7b9-5d6c-4bf4-bae5-9ee85c3a7dc2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.075,
        "w": 0.929,
        "x": 0.035,
        "y": 0.755
      },
      "kind": "list",
      "text": "Continue partnering discussions for Company's preclinical assets (KV3 and PanNav programs) and Merck Collaboration",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d69c866d-c107-468b-926b-fea746aa0541",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.035,
        "w": 0.367,
        "x": 0.039,
        "y": 0.141
      },
      "kind": "title",
      "text": "2023 is a pivotal year for Bionomics",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d378d28a-eff9-42f3-9b2c-024e42378a6f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.157,
        "x": 0.039,
        "y": 0.075
      },
      "kind": "title",
      "text": "Next steps",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cdda4a6a-ccd7-4b6e-9f13-85c4510b3285",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Storytelling: the closing ask",
      "slug": "closing-ask",
      "agent": "storyteller",
      "layer": "slide",
      "matchId": "e851d4a1-055a-451b-8193-9e8705ff541a",
      "evidence": "2023 is a pivotal year for Bionomics",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 27,
      "from": 23,
      "beatId": "478e8441-ca9a-4555-beba-f0377b06b183",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Action",
      "beatSlug": "aida-action",
      "evidence": "The document concludes with a call to action, outlining next steps and a Q&A session.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [
    {
      "to": 27,
      "from": 23,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "4a7e8e8a-3d2a-47a9-96df-e4aa87ebad49",
      "evidence": "The document concludes with a call to action, emphasizing the importance of next steps in BNC210's development.",
      "position": 1,
      "objective": "To highlight the importance of next steps in BNC210's development",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}